BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Biolato M, Miele L, Vero V, Racco S, Stasi CD, Iezzi R, Zanché A, Pompili M, Rapaccini GL, Torre GL, Gasbarrini A, Grieco A. Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: Serum sodium predicts survival. World J Gastroenterol 2014; 20(25): 8158-8165 [PMID: 25009388 DOI: 10.3748/wjg.v20.i25.8158]
URL: https://www.wjgnet.com/1007-9327/full/v20/i25/8158.htm
Number Citing Articles
1
Ya Ruth Huo, Hao Xiang, Michael Vinchill Chan, Christine Chan. Survival, tumour response and safety of 70‐150 μm versus 100‐300 μm doxorubicin drug‐eluting beads in transarterial chemoembolisation for hepatocellular carcinomaJournal of Medical Imaging and Radiation Oncology 2019; 63(6): 802 doi: 10.1111/1754-9485.12971
2
Marco Biolato, Giulia Gallusi, Massimo Iavarone, Giuseppe Cabibbo, Simona Racco, Adriano De Santis, Cristina della Corte, Marcello Maida, Adolfo Francesco Attili, Angelo Sangiovanni, Calogero Cammà, Giuseppe La Torre, Antonio Gasbarrini, Antonio Grieco. Prognostic ability of BCLC-B Subclassification in Patients with Hepatocellular Carcinoma Undergoing Transarterial ChemoembolizationAnnals of Hepatology 2018; 17(1): 110 doi: 10.5604/01.3001.0010.7542
3
Zhi-Huan Lin, Xing Li, Ying-Fen Hong, Xiao-Kun Ma, Dong-Hao Wu, MingSheng Huang, Zhan-Hong Chen, Jie Chen, Min Dong, Li Wei, Tian-Tian Wang, Dan-Yun Ruan, Ze-Xiao Lin, Xiang Zhong, Yan-Fang Xing, Jing-Yun Wen, Xiang-Yuan Wu, Qu Lin. Alanine aminotransferase to hemoglobin ratio is an indicator for disease progression for hepatocellular carcinoma patients receiving transcatheter arterial chemoembolizationTumor Biology 2016; 37(3): 2951 doi: 10.1007/s13277-015-4082-y
4
Aline Mähringer‐Kunz, Franziska Wagner, Felix Hahn, Arndt Weinmann, Sebastian Brodehl, Sebastian Schotten, Jan B. Hinrichs, Christoph Düber, Peter R. Galle, Daniel Pinto dos Santos, Roman Kloeckner. Predicting survival after transarterial chemoembolization for hepatocellular carcinoma using a neural network: A Pilot StudyLiver International 2020; 40(3): 694 doi: 10.1111/liv.14380
5
Shanshan Liu, Yunwei Han, Zhihong Zhang, Fei Wu. Effectiveness of c-TACE Combined With Sorafenib Versus c-TACE Monotherapy in Advanced Hepatocellular Carcinoma: A Retrospective StudyClinical Medicine Insights: Oncology 2023; 17 doi: 10.1177/11795549221146648
6
M. Cuesta, A. Garrahy, C. J. Thompson. SIAD: practical recommendations for diagnosis and managementJournal of Endocrinological Investigation 2016; 39(9): 991 doi: 10.1007/s40618-016-0463-3
7
LiuCun Zhu, XiJia Chen, Xiangyin Kong, Yu-Dong Cai. Investigation of the roles of trace elements during hepatitis C virus infection using protein-protein interactions and a shortest path algorithmBiochimica et Biophysica Acta (BBA) - General Subjects 2016; 1860(11): 2756 doi: 10.1016/j.bbagen.2016.05.018
8
Hong-Lin Chen, Yu-Hua Chen, Lin Du, Yi-Ping Song, Bin Zhu. Elevated serum alpha-fetoprotein levels are associated with poor prognosis of hepatocellular carcinoma after surgical resection: A systematic review and meta-analysisArab Journal of Gastroenterology 2021; 22(1): 12 doi: 10.1016/j.ajg.2020.09.004
9
Aoife Garrahy, Martin Cuesta, Christopher J. Thompson. Thyroid DiseasesEndocrinology 2018; : 1 doi: 10.1007/978-3-319-38681-2_14-1
10
Jordi Sánchez-Delgado, Mercedes Vergara, Salvador Machlab, Alba Lira, Carlos Gómez Zaragoza, Eva Criado, Mercè Rosinach, Lissette Batista, Beatriz Arau, Mercè Roget, Jordi Ortiz, Caridad Garcia, Pau Sort, Meritxell Casas, Blai Dalmau, Montserrat Forné, Joan Falcó, Mireia Miquel. Analysis of survival and prognostic factors in treatment of hepatocellular carcinoma in Spanish patients with drug-eluting bead transarterial chemoembolizationEuropean Journal of Gastroenterology & Hepatology 2018; 30(12): 1453 doi: 10.1097/MEG.0000000000001229
11
Suk Kyun Hong, Kwang-Woong Lee, Su young Hong, Sanggyun Suh, Kwangpyo Hong, Eui Soo Han, Jeong-Moo Lee, YoungRok Choi, Nam-Joon Yi, Kyung-Suk Suh. Efficacy of Liver Resection for Single Large Hepatocellular Carcinoma in Child-Pugh A Cirrhosis: Analysis of a Nationwide Cancer Registry DatabaseFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.674603
12
Martin Cuesta, C.J. Thompson. The syndrome of inappropriate antidiuresis (SIAD)Best Practice & Research Clinical Endocrinology & Metabolism 2016; 30(2): 175 doi: 10.1016/j.beem.2016.02.009
13
Fabrizio Chegai, Antonio Orlacchio, Stefano Merolla, Serena Monti, Lorenzo Mannelli. Intermediate hepatocellular carcinoma: the role of transarterial therapyHepatic Oncology 2015; 2(4): 399 doi: 10.2217/hep.15.32
14
Aoife Garrahy, Martin Cuesta, Christopher J. Thompson. Hypothalamic-Pituitary DiseasesEndocrinology 2018; : 405 doi: 10.1007/978-3-319-44444-4_14
15
Marie Vogeler, Isabelle Mohr, Jan Pfeiffenberger, Simon David Sprengel, Miriam Klauss, Andreas Teufel, De-Hua Chang, Christoph Springfeld, Thomas Longerich, Uta Merle, Arianeb Mehrabi, Karl Heinz Weiss, Markus Mieth. Applicability of scoring systems predicting outcome of transarterial chemoembolization for hepatocellular carcinomaJournal of Cancer Research and Clinical Oncology 2020; 146(4): 1033 doi: 10.1007/s00432-020-03135-8
16
Zhaohui Bai, Wentao Xu, Lu Chai, Xiaojie Zheng, Nahum Méndez-Sánchez, Cyriac Abby Philips, Gang Cheng, Xingshun Qi. Effects of Short-Term Human Albumin Infusion for the Prevention and Treatment of Hyponatremia in Patients with Liver CirrhosisJournal of Clinical Medicine 2022; 12(1): 107 doi: 10.3390/jcm12010107